130 related articles for article (PubMed ID: 11392629)
1. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.
Salamone JD; Correa M; Carlson BB; Wisniecki A; Mayorga AJ; Nisenbaum E; Nisenbaum L; Felder C
Life Sci; 2001 Apr; 68(22-23):2579-84. PubMed ID: 11392629
[TBL] [Abstract][Full Text] [Related]
2. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
3. Tremulous jaw movements in rats: a model of parkinsonian tremor.
Salamone JD; Mayorga AJ; Trevitt JT; Cousins MS; Conlan A; Nawab A
Prog Neurobiol; 1998 Dec; 56(6):591-611. PubMed ID: 9871939
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
Mayorga AJ; Cousins MS; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Eur J Pharmacol; 1999 Jan; 364(1):7-11. PubMed ID: 9920179
[TBL] [Abstract][Full Text] [Related]
5. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
6. Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
Salamone JD; Carlson BB; Rios C; Lentini E; Correa M; Wisniecki A; Betz A
Behav Brain Res; 2005 Jan; 156(2):173-9. PubMed ID: 15582103
[TBL] [Abstract][Full Text] [Related]
7. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
8. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
Carlson BB; Wisniecki A; Salamone JD
Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151
[TBL] [Abstract][Full Text] [Related]
9. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
10. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
Ishiwari K; Mingote S; Correa M; Trevitt JT; Carlson BB; Salamone JD
J Neurosci Methods; 2004 Dec; 140(1-2):39-46. PubMed ID: 15589332
[TBL] [Abstract][Full Text] [Related]
11. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.
Collins LE; Paul NE; Abbas SF; Leser CE; Podurgiel SJ; Galtieri DJ; Chrobak JJ; Baqi Y; Müller CE; Salamone JD
Pharmacol Biochem Behav; 2011 Sep; 99(3):414-22. PubMed ID: 21640750
[TBL] [Abstract][Full Text] [Related]
12. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.
Mayorga AJ; Carriero DL; Cousins MS; Gianutsos G; Salamone JD
Pharmacol Biochem Behav; 1997 Feb; 56(2):273-9. PubMed ID: 9050085
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent.
Gandía J; Morató X; Stagljar I; Fernández-Dueñas V; Ciruela F
Behav Brain Res; 2015 Jul; 288():103-6. PubMed ID: 25862943
[TBL] [Abstract][Full Text] [Related]
14. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
15. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
[TBL] [Abstract][Full Text] [Related]
16. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
Podurgiel S; Collins-Praino LE; Yohn S; Randall PA; Roach A; Lobianco C; Salamone JD
Pharmacol Biochem Behav; 2013 Apr; 105():105-11. PubMed ID: 23360954
[TBL] [Abstract][Full Text] [Related]
17. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
18. Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.
Salamone J; Baskin P
Pharmacol Biochem Behav; 1996 Jan; 53(1):179-83. PubMed ID: 8848448
[TBL] [Abstract][Full Text] [Related]
19. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
Carlson BB; Trevitt JT; Salamone JD
Pharmacol Biochem Behav; 2000 Apr; 65(4):683-9. PubMed ID: 10764923
[TBL] [Abstract][Full Text] [Related]
20. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Correa M; Wisniecki A; Betz A; Dobson DR; O'Neill MF; O'Neill MJ; Salamone JD
Behav Brain Res; 2004 Jan; 148(1-2):47-54. PubMed ID: 14684247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]